Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to Highly Active Antiretroviral Therapy (HAART) medication regimens among HIV-positive men and women

Journal of Personality Assessment

Volumn 89, Issue 3, 2007, Pages 277-290

  Cruess, Dean G ^a   Minor, Sarah ^b   Antoni, Michael H ^b,c   Millon, Theodore ^b,d  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Department of Biology   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d Institute for Advanced Studies in Personology and Psychopathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DIARRHEA; FATIGUE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; MEN'S HEALTH; NAUSEA; ORAL PARESTHESIA; PATIENT COMPLIANCE; PERIPHERAL NEUROPATHY; PROGNOSIS; PSYCHOLOGICAL RATING SCALE; SCORING SYSTEM; SOCIAL PSYCHOLOGY; STRUCTURED INTERVIEW; TREATMENT FAILURE; VOMITING; WOMEN'S HEALTH;

EID: 37249059331     PISSN: 00223891     EISSN: None     Source Type: Journal    
DOI: 10.1080/00223890701629805     Document Type: Article

References (62)

1. Altice, F. L., Mostashari, F., & Friedland, G. H. (2001). Trust and acceptance of and adherence to antiviral therapy. Journal of Acquired Immune Deficiency Syndromes, 28, 47-58.
2. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3. Antoni, M. H., Carrico, A. W., Duran, R. E., Spitzer, S., Penedo, F., Ironson, G., et al. (2006). Randomized clinical trial of cognitive behavioral stress management on human immunodeficiency virus viral load in gay men treated with highly active antiretroviral therapy. Psychosomatic Medicine, 68, 143-151.
4. Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Chesney, M., & Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 229-234.
5. Beck, A. T., Ward, C. K., Mendelson, M., Mack, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
6. Bremer, B. (1995). Absence of control over health and the psychological adjustment to end-stage renal disease. Annals of Behavioral Medicine, 17, 227-233.
7. Bright, D. C. (1999). Antiretroviral therapy for HIV infection: A review of current medications and therapies. Journal of the American Optometric Association, 70, 355-383.
8. Byrnes, D. M., Antoni, M. H., Goodkin, K., Efantis-Potter, J., Asthana, D., Simon, T., et al. (1998). Stressful events, pessimism, natural killer cell cytotoxicity, and cytotoxic/suppressor T cells in HIV+ black women at risk for cervical cancer. Psychosomatic Medicine, 60, 714-722.
9. Caldwell, J. R. (1976). Drug regimens for long-term therapy of hypertension. Geriatrics, 31, 115-119.
10. Cameron, D., Heath-Chiozzi, M., Danner, S., Cohen, C., Kravcik, S., Maurath, C., et al. (1998). Randomized placebo-controlled trial of ritinavir in advanced HIV-1 disease. Lancet, 351, 543-549.
11. Carney, R., Freedland, K., Eisen, S., Rich, M., & Jaffe, A. (1995). Major depression and medication adherence in elderly patients with coronary heart disease. Health Psychology, 14, 88-90.
12. Carrieri, M. P., Leport, C., Protopopescu, C., Cassuto, J. P., Bouvet, E., Peyramond, D., et al. (2006). Factors associated with nonadherence to highly active antiretroviral therapy: A 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. Journal of Acquired Immune Deficiency Syndrome, 41, 477-485.
13. Chacko, R. C., Harper, R. G., Kunik, M., & Young, J. (1996). Relationship of psychiatric morbidity and psychosocial factors in organ transplant candidates. Psychosomatics, 37, 100-107.
14. Chesney, M. (2003). Review: Adherence to HAART Regimens. AIDS Patient Care and STDs, 17, 169-177.
15. Chesney, M. A., Ickovics, J.R., Chambers, D.B., Gifford, A. L., Neidig, J., Zwickl, B., et al. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments: Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12, 255-266.
16. Chesney, M. A., Ickovics, J., Hecht, F. M., Sikipia, G., & Rabkin, J. (1999). Adherence: A necessity for successful HIV combination therapy. AIDS, 13, S271-S278.
17. Christensen, A. J., & Smith, T. W. (1995). Personality and patient adherence: Correlates of the Five-factor model in renal dialysis. Journal of Behavioral Medicine, 18, 305-313.
18. Costa, P. T., & McCrae, R. R. (1992). Revised NEO Personality Inventory: Professional manual. Odessa, FL: Psychological Assessment Resources.
19. Coutts, J. A., Gibson, N. A., & Paton, J. Y. (2002). Measuring compliance with inhaled medication in asthma. Archives of Disease in Childhood, 67, 332-333.
20. Cozzi-Lepri, A., Miller, V., Phillips, A. N., Rabenau, H., Sabin, C. A., & Staszewski, S. (2001). The virological response to highly active antiretroviral therapy over the first 24 weeks of therapy according to the pretherapy viral load and the weeks 4-8 viral load. AIDS, 15, 47-54.
21. Cuneo, W. D., & Snyder, D. E. (1989). Enhancing patient compliance with tuberculosis therapy. Clinics in Chest Medicine, 10, 375-380.
22. Deeks, S. G., Hecht, F. M., Swanson, M., Elbeik, T., Loftus, R., Cohen, P. T., et al. (1999). HIV, RNA, and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: Response to both initial and salvage therapy. AIDS, 13, 135-143.
23. First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B.W. (1997). Structured Clinical Interview for DSM-IV Axis I Disorders-Non-patient Edition (SCID-IV/NP Version 2.0 - 4/97 revision). New York: Biometrics Research Department, New York State Psychiatric Institute.
24. Gallant, J., & Block, D. (1998). Adherence to antiretroviral regimens in HIV-infected patients: Results of a survey among physicians and patients. Journal of the International Association of Physicians for AIDS Care, 4, 32-35.
25. Gehi, A., Haas, D., Pipkin, S., & Whooley, M. A. (2005). Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Archives of Internal Medicine, 165, 2508-2513.
26. Gordillo, V., del Amo, J., Soriano, V., & Gonzalez-Lahoz, J. (1999). Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS, 13, 1763-1769.
27. Gonzalez, J. S., Penedo, F. J., Antoni, M. H., Duran, R. E., Fernandez, M. I., McPherson-Baker, S., et al. (2004). Social support, positive states of mind, and HIV treatment adherence in men and women living with HIV/AIDS. Health Psychology, 23, 413-418.
28. Gulick, R., Mellors, J., Havlir, D., Eron, J., Gonzalez, C., McMahon, D., et al. (1997). Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. New England Journal of Medicine, 337, 734-739.
29. Hamilton, A. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry, 23, 56-61.
30. Havlir, D. V., Schrier, R. D., Torriani, F. J., Chervenak, K., Hwang, J. Y., & Boom, W. H. (2000). Effect of potent antiretroviral therapy on immune responses to Mycobacterium avium in human immunodeficiency virus-infected subjects. Journal of Infectious Disease, 182, 1658-1663.
31. Hershberger, P. J., Robertson, K. B., & Markert, R. J. (1999). Personality and appointment keeping adherence in cardiac rehabilitation. Journal of Cardiopulmonary Rehabilitation, 19, 106-111.
32. Holzemer, W. L., Henry, S. B., Portillo, C. J., & Miramontes, H. (1999). The client adherence profiling-intervention tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: A pilot study. Journal of Association of Nurses in AIDS Care, 11, 36-44.
33. Hoyle, R. H., Fejfar, M. C., & Miller, J. D. (2000). Personality and sexual risk taking: A quantitative review. Journal of Personality, 68, 1203-1231.
34. Kitchen, C. M., Kitchen, S. G., Dubin, J. A., & Gottlieb, M. S. (2001). Initial virological and immunologic response to highly active antiretroviral therapy predicts long-term clinical outcome. Clinical Infectious Diseases, 33, 466-472.
35. Kolitz, S. L., Antoni, M. H., & Green, C. J. (1988). Personality style and immediate help-seeking responses following the onset of myocardial infarction. Psychology & Health, 2, 259-289.
36. Ladd, G. T., & Petry N. M. (2003). Antisocial personality in treatment-seeking cocaine abusers: Psychosocial functioning and HIV risk. Journal of Substance Abuse Treatment, 4, 323-330.
37. Llabre, M. M., Weaver, K. E., Durán, R. E., Antoni, M. H., McPherson-Baker, S., & Schneiderman. N. A. (2006). A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV+ adults. AIDS Patient Care and STDs, 20, 701-711.
38. Low-Boer, S., Yip, B., O'Shaughnessy, M. V., Hogg, R. S., & Montaner, I. S. (2000). Adherence to triple therapy and viral load response. Journal of Acquired Immune Deficiency Syndromes, 23, 360-361.
39. Lucas, G. M., Chaisson, R. E., Moore, R. D. (1999). Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologie failure and adverse drug reactions. Annals of Internal Medicine, 131, 81-87.
40. Maher, K., Klimas, N., Fletcher, M. A., Cohen, V., Maggio, C. M. Triplett, J., et al. (2000). Disease progression, adherence, and response to protease inhibitor therapy of human therapy of human immunodeficiency virus infection in an urban veteran's affairs medical center. Journal of Acquired Immune Deficiency Syndrome, 22, 358-363.
41. McMahon, R. C., Malow, R. M., & Jennings, T. E. (2000). Personality, stress, and social support in HIV risk prediction. AIDS and Behavior, 4, 399-410.
42. McPherson-Baker, S., Jones, D., Duran, R. E., Klimas, N., & Schneiderman N. (2005). Development and implementation of a medication adherence training instrument for persons living with HIV: The MATI. Behavior Modification, 29, 286-317.
43. Meystre-Agustoni, G., Dubois-Arber, F., Cochland, P., & Telelnti, A. (2000). Antiretroviral therapies from the patient's perspective. AIDS Care, 12, 712-721.
44. Millon, T., Antoni, M., Millon, C., Meagher, S., & Grossman, S. (2001). Millon Behavioral Medicine Diagnostic. Minneapolis, MN: NCS Assessments.
45. Millon, T., & Davis, R. (1996). Disorders of personality: DSM-IV and beyond. New York: Wiley.
46. Millon, T., Green, C. J., Meagher R. B., & Millon, C. (1982). Millon Behavioral Health Inventory. Minneapolis, MN: NCS Assessments.
47. Montaner, J. S. G., Reiss, P., Cooper, D., Vella, S., Harris, M., Conway, B., et al. (1998). A randomized, double-blind trial comparing combinations of nevirapine, didanosine, and zidovudine for HIV-infected patients. Journal of the American Medical Association, 279, 930-937.
48. Palella, F. J., Delany, K., Moorman, A., Loveless, M., Fuhrer, J., Satten, G., et al. (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine, 338, 850-860.
49. Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squier, C., et al. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21-30.
50. Pedhazur, E. J. (1997). Multiple regression in behavioral research (3rd ed.). Fort Worth, TX: Harcourt Brace.
51. Penedo, F. J., Gonzales, J. S., Dahn, J. R., Antoni, M., Malow, R., Costa, P., et al. (2003). Personality, quality of life and HAART adherence among men and women living with HIV/AIDS. Journal of Psychosomatic Research, 54, 271-278.
52. Power, C., Selnes, O., Grim, J., & McArthur, J. (1995). HIV Dementia Scale: A rapid screening test. Journal of AIDS and Human Retroviruses, 8, 273-278.
53. Rabkin, J. G., & Chesney, M. (1999). Treatment adherence to HIV medications: The Achilles heel of new therapeutics. In D. G. Ostrow & S. C. Kalichman (Eds.), Psychosocial and public health impacts of new HIV therapies (pp. 61-82). New York: Kluwer Academic/Plenum.
54. Singh, N., Berman, S. M., Swindells, S., Justis, J. C., Mohr, J. A., & Wagener, M. M. (1999). Adherence to immunodeficiency virus-infected patients to antiretroviral therapy. Clinical Infectious Diseases, 29, 824-830.
55. SPSS, Inc. (2005). SPSS Base 13.0 for Windows User's Guide. Chicago, IL: SPSS Inc.
56. Starace, F., Massa, A., Amico, K. R., & Fisher, J. D. (2006). Adherence to antiretroviral therapy: An empirical test of the information-motivation-behavioral skills model. Health Psychology, 25, 153-162.
57. Sternhall, P. S., & Corr, M. J. (2002). Psychiatric morbidity and adherence to antiretroviral medication in patients with HIV/AIDS. Australian and New Zealand Journal of Psychiatry, 36, 528-533.
58. Trobst, K. K., Herbst, J. H., Masters, H. L., & Costa, P. T. (2002). Personality pathways to unsafe sex: Personality, condom use, and HIV risk behaviors. Journal of Research in Personality, 36, 117-133.
59. Valdez, L., Lederman, M., Woolley, I., Walker, C. J., Vernon, L. T., Hise, A., et al. (1999). Human immunodeficiency virus 1 protease inhibitors in clinical practice: Predictors of virological outcome. Archives of Internal Medicine, 159, 1771-1776.
60. Weaver, K., Llabre, M., Durán, R. E., Antoni, M. H., Ironson, G., Penedo, F., et al. (2005). A stress and coping model of medication adherence and viral load in HIV+ men and women on highly active antiretroviral therapy. Health Psychology, 24, 385-392.
61. Wilkinson, G. S. (1993). The Wide Range Achievement Test3rd Edition (WRAT3). Wilmington, DE: Wide Range, Inc.
62. Williams, J. (1980). Structured Interview Guide for the Hamilton Depression and Anxiety Scales (SIGH-AD). New York: Biometrics Research Department, New York State Psychiatric Institute.